drugset / Trial / NCT07288957
A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors
NaSequentialOpen-labelTreatment
Summary
This is a first-in-human (FIH), multicenter, non-randomized, openlabel, phase 1 study of ABSK131 in patients with MTAP-Deficient Advanced/Metastatic Solid Tumors to evaluate the safety, tolerability, PK, and preliminary antitumor efficacy.
Timeline
- Start
- 2025-07-22
- Primary completion
- 2028-12-30
- Completion
- 2029-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABSK131 | Unknown | — | Oral |
Indications
No indication recorded.